• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表面活性蛋白 D 作为小儿镰状细胞病患者肺部并发症的标志物:与肺功能测试的关系。

Surfactant protein D as a marker for pulmonary complications in pediatric patients with sickle cell disease: Relation to lung function tests.

机构信息

Faculty of Medicine, Pediatrics Department, Ain Shams University, Cairo, Egypt.

Clinical Pathology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Pediatr Pulmonol. 2019 May;54(5):610-619. doi: 10.1002/ppul.24257. Epub 2019 Jan 22.

DOI:10.1002/ppul.24257
PMID:30672154
Abstract

BACKGROUND

Surfactant protein D (SP-D) is considered a candidate biomarker for lung integrity and for disease progression.

AIM

We determined the level of SP-D in children and adolescents with SCD and assessed its possible relation to pulmonary complications and lung function.

METHODS

Serum SP-D levels were assessed in 50 SCD patients compared with 30 healthy controls. High-resolution computerized tomography (HRCT) of the chest was done. Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV ), FEV /FVC% and forced expiratory flow rate during 25-75% of expiration (FEF25-75%) were determined.

RESULTS

SP-D was significantly higher in SCD patients than controls, particularly patients with sickle cell anemia than those with sickle β-thalassemia. SP-D levels were significantly associated with increasing severity of interstitial lung disease. The highest SP-D levels were observed among patients with restrictive lung disease followed by mixed type then obstructive lung disease. SP-D was positively correlated to HbS and serum ferritin while negatively correlated to duration of hydroxyurea treatment and parameters of pulmonary functions. ROC curve analysis revealed that SP-D cutoff value 720 ng/mL could significantly detect the presence of abnormal pulmonary function among SCD patients with 82% sensitivity and 88% specificity. Logistic regression analysis showed that SP-D is an independent factor related to abnormal pulmonary function in SCD.

CONCLUSIONS

SP-D may be a promising biomarker for screening of SCD patients for risk of later pulmonary complications.

摘要

背景

表面活性蛋白 D(SP-D)被认为是肺完整性和疾病进展的候选生物标志物。

目的

我们测定了 SCD 患儿和青少年的 SP-D 水平,并评估其与肺部并发症和肺功能的可能关系。

方法

将 50 例 SCD 患者与 30 例健康对照者进行比较,评估血清 SP-D 水平。行胸部高分辨率计算机断层扫描(HRCT)。测定用力肺活量(FVC)、第 1 秒用力呼气量(FEV )、FEV/FVC%和 25%-75%呼气流速(FEF25-75%)。

结果

SCD 患者的 SP-D 明显高于对照组,尤其是镰状细胞贫血患者高于镰状细胞β-地中海贫血患者。SP-D 水平与间质性肺病严重程度呈显著正相关。在限制性肺疾病患者中观察到最高的 SP-D 水平,其次是混合性然后是阻塞性肺疾病。SP-D 与 HbS 和血清铁蛋白呈正相关,与羟基脲治疗时间和肺功能参数呈负相关。ROC 曲线分析显示,SP-D 截断值 720ng/ml 可显著检测出 SCD 患者异常肺功能的存在,其敏感性为 82%,特异性为 88%。Logistic 回归分析显示,SP-D 是 SCD 患者异常肺功能的独立相关因素。

结论

SP-D 可能是筛查 SCD 患者发生肺部并发症风险的有前途的生物标志物。

相似文献

1
Surfactant protein D as a marker for pulmonary complications in pediatric patients with sickle cell disease: Relation to lung function tests.表面活性蛋白 D 作为小儿镰状细胞病患者肺部并发症的标志物:与肺功能测试的关系。
Pediatr Pulmonol. 2019 May;54(5):610-619. doi: 10.1002/ppul.24257. Epub 2019 Jan 22.
2
Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.候选血清生物标志物在系统性硬化症相关间质性肺病中的表现。
Arthritis Rheumatol. 2019 Jun;71(6):972-982. doi: 10.1002/art.40815. Epub 2019 Apr 26.
3
Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.血清 Krebs von den Lungen-6、表面活性剂蛋白 D 和基质金属蛋白酶-2 浓度作为石棉肺和矽肺患者的诊断生物标志物:一项病例对照研究。
BMC Pulm Med. 2017 Nov 17;17(1):144. doi: 10.1186/s12890-017-0489-0.
4
Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.小儿间质性肺疾病中的血清KL-6及表面活性蛋白A和D
Chest. 2005 Jan;127(1):403-7. doi: 10.1378/chest.127.1.403.
5
Pulmonary function studies in Kuwaiti children with sickle cell disease and elevated Hb F.科威特患有镰状细胞病且Hb F升高的儿童的肺功能研究。
Int J Clin Pract. 2005 Feb;59(2):163-7. doi: 10.1111/j.1742-1241.2004.00216.x.
6
Airway hyperreactivity in children with sickle cell disease.镰状细胞病患儿的气道高反应性
J Pediatr. 1997 Aug;131(2):278-83. doi: 10.1016/s0022-3476(97)70166-5.
7
Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes.血清表面活性蛋白D作为衡量2型糖尿病肥胖患者肺部受累情况的生物标志物。
J Clin Endocrinol Metab. 2017 Nov 1;102(11):4109-4116. doi: 10.1210/jc.2017-00913.
8
Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.系统性硬皮病患者血清表面活性蛋白 D 浓度:间质性肺病严重程度的潜在标志物。
Best Pract Res Clin Rheumatol. 2018 Aug;32(4):541-549. doi: 10.1016/j.berh.2019.01.005. Epub 2019 Feb 14.
9
Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.血清apelin作为镰状细胞病儿童和青少年亚临床心肺并发症的一种新型非侵入性标志物。
Blood Cells Mol Dis. 2016 Mar;57:1-7. doi: 10.1016/j.bcmd.2015.11.001. Epub 2015 Nov 10.
10
Serum surfactant protein-A, but not surfactant protein-D or KL-6, can predict preclinical lung damage induced by smoking.血清表面活性蛋白A而非表面活性蛋白D或KL-6能够预测吸烟引起的临床前肺损伤。
Biomarkers. 2008 Jun;13(4):385-92. doi: 10.1080/13547500801903651.

引用本文的文献

1
Complex Evaluation of Surfactant Protein A and D as Biomarkers for the Severity of COPD.表面活性蛋白 A 和 D 作为 COPD 严重程度的生物标志物的综合评估。
Int J Chron Obstruct Pulmon Dis. 2022 Jul 2;17:1537-1552. doi: 10.2147/COPD.S366988. eCollection 2022.
2
Lung injury induced by short-term mechanical ventilation with hyperoxia and its mitigation by deferoxamine in rats.大鼠短期高氧机械通气致肺损伤及去铁胺的缓解作用。
BMC Anesthesiol. 2020 Aug 1;20(1):188. doi: 10.1186/s12871-020-01089-5.